Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab

Abstract

Molluscum contagiosum virus (MCV) infection in the setting of atopic dermatitis (AD), also known as eczema molluscatum, can represent a significant treatment challenge to the dermatologist. We report four patients with severe AD and disseminated MCV infection who experienced clearance of their MCV infection following treatment with dupilumab, a fully human monoclonal antibody against interleukin(IL)‐4 receptor alpha licenced for the treatment of moderate to severe AD.

This article is protected by copyright. All rights reserved.

http://bit.ly/2t5MG1W